BiomX Inc. (PHGE) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
BiomX Inc. (PHGE) Bundle
Evaluate BiomX Inc.'s (PHGE) financial outlook with expertise! This (PHGE) DCF Calculator provides pre-filled financial data and offers full flexibility to modify revenue growth, WACC, margins, and other critical assumptions to align with your projections.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | -.1 | -.4 | -.4 | -.6 | -.7 | -.9 | -1.1 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 166.42 | 25 | 25 | 25 | 25 | 25 |
EBITDA | -20.2 | -27.9 | -32.9 | -23.7 | -22.8 | -.4 | -.6 | -.7 | -.9 | -1.1 |
EBITDA, % | 100 | 100 | 100 | 17649.25 | 6390.76 | 100 | 100 | 100 | 100 | 100 |
Depreciation | .3 | 2.2 | 2.6 | 2.5 | .9 | -.1 | -.1 | -.1 | -.2 | -.2 |
Depreciation, % | 100 | 100 | 100 | -1880.6 | -243.98 | 20 | 20 | 20 | 20 | 20 |
EBIT | -20.5 | -30.1 | -35.5 | -26.2 | -23.7 | -.4 | -.6 | -.7 | -.9 | -1.1 |
EBIT, % | 100 | 100 | 100 | 19529.85 | 6634.73 | 100 | 100 | 100 | 100 | 100 |
Total Cash | 82.3 | 56.3 | 62.1 | 33.3 | 15.9 | -.1 | -.1 | -.1 | -.2 | -.2 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .2 | .0 | -.1 | .6 | .6 | -.1 | -.1 | -.1 | -.2 | -.2 |
Account Receivables, % | 100 | 100 | 100 | -423.13 | -160.78 | 20 | 20 | 20 | 20 | 20 |
Inventories | 2.0 | .0 | .1 | .4 | .0 | -.2 | -.2 | -.3 | -.3 | -.4 |
Inventories, % | 100 | 100 | 100 | -294.78 | 0 | 40 | 40 | 40 | 40 | 40 |
Accounts Payable | 3.3 | 2.3 | 2.8 | .8 | 1.4 | -.1 | -.1 | -.1 | -.2 | -.2 |
Accounts Payable, % | 100 | 100 | 100 | -611.94 | -386.83 | 20 | 20 | 20 | 20 | 20 |
Capital Expenditure | -1.3 | -1.0 | -3.7 | -.1 | -.1 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | 83.58 | 14.01 | 0 | 0 | 0 | 0 | 0 |
Tax Rate, % | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 |
EBITAT | -18.9 | -29.9 | -35.5 | -26.2 | -23.7 | -.4 | -.5 | -.7 | -.9 | -1.1 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -18.8 | -27.4 | -36.2 | -26.8 | -21.9 | -1.2 | -.6 | -.8 | -1.0 | -1.2 |
WACC, % | 13.85 | 14.8 | 14.87 | 14.87 | 14.87 | 14.65 | 14.65 | 14.65 | 14.65 | 14.65 |
PV UFCF | ||||||||||
SUM PV UFCF | -3.1 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -1 | |||||||||
Terminal Value | -10 | |||||||||
Present Terminal Value | -5 | |||||||||
Enterprise Value | -8 | |||||||||
Net Debt | -1 | |||||||||
Equity Value | -7 | |||||||||
Diluted Shares Outstanding, MM | 5 | |||||||||
Equity Value Per Share | -1.42 |
What You Will Receive
- Comprehensive Financial Model: BiomX Inc.'s (PHGE) actual data provides an accurate DCF valuation.
- Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential drivers.
- Real-Time Calculations: Automatic updates allow you to see results immediately as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for expert-level valuation.
- Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.
Key Features
- 🔍 Real-Life PHGE Financials: Pre-filled historical and projected data for BiomX Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate BiomX’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize BiomX’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for BiomX Inc. (PHGE).
- Step 2: Review BiomX's pre-filled financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose BiomX Inc. (PHGE) Calculator?
- Designed for Experts: A sophisticated tool utilized by biopharma analysts, researchers, and investment professionals.
- Comprehensive Data: BiomX's historical and projected financials integrated for precision.
- Flexible Scenario Analysis: Effortlessly model various forecasts and assumptions.
- Insightful Outputs: Instantly computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout.
Who Should Use BiomX Inc. (PHGE)?
- Biotechnology Students: Explore cutting-edge research and gain practical experience with real-world applications.
- Researchers: Utilize advanced models and data in your studies surrounding microbiome therapies.
- Investors: Evaluate your investment strategies and analyze the potential of BiomX Inc. (PHGE) within the biotech sector.
- Industry Analysts: Enhance your analysis with a customizable model tailored for biotech companies.
- Healthcare Entrepreneurs: Understand how innovative companies like BiomX Inc. (PHGE) are transforming the healthcare landscape.
What the Template Contains
- Pre-Filled DCF Model: BiomX Inc.’s (PHGE) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate BiomX Inc.’s (PHGE) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.